Leverkusen (pta002/02.12.2021/01:05) - Leverkusen, Germany, December 2, 2021 - On November 29, 2021, Biofrontera AG (ISIN: DE0006046113) announced that its US subsidiary Biofrontera Inc. had entered into a private placement in the amount of USD 15 million (gross proceeds).
Today, Biofrontera Inc. (Nasdaq: BFRI) closed the private placement of 2,875,143 common shares and warrants with an institutional investor. The combined purchase price for one common share (or common share equivalent) with warrant is USD 5.25, priced at-the-market under Nasdaq rules. The warrants have an exercise price of $5.25 per share, will be immediately exercisable, and will expire five years from the issuance date.
As of today, following the successful closing of the private placement, Biofrontera AG holds approximately 52% shares in Biofrontera Inc.
Biofrontera AG, Hemmelrather Weg 201, 51377 Leverkusen
Tel: +49 (0214) 87 63 2 0, Fax: +49 (0214) 87 63 290
Hemmelrather Weg 201
|contact person:||Investor Relations|
|phone:||+49 (0) 214 87 63 20|
|stock exchanges:||regulated market in Dusseldorf, Frankfurt; free market in Munich, free market in Stuttgart; open market in Berlin, Tradegate|
|other stock exchanges:||Nasdaq|